<DOC>
	<DOCNO>NCT00662285</DOCNO>
	<brief_summary>Description effect standard iron supplement iron status blood donor Hypothesis : For person group ( group `` without iron supplement '' group b `` iron supplement '' ) individual biological variation reticulocyte , test day 1 day 8 described . Groups b compare iron status day 1 day 8 . - H1 null : There significant intraindividual difference reticstatus day 1 day 8 , group . - H2 null : There significant intraindividual difference reticstatus day 1 day 8 , group b - H3 null : There significant difference iron status two group , b , day 1 day 8 .</brief_summary>
	<brief_title>Description Iron Status Blood Donors</brief_title>
	<detailed_description>The purpose study : The purpose study describe intra- individual biological variation reticulocyte parameter establish blood donor . The aim also compare iron status reticulocyte parameter group establish donor offer iron supplement , comparable group offer iron supplement , time donation one week donation . Design : The design prospective longitudinal intervention-study , randomise subject iron supplement/ iron supplement group . Materials method : Each subject test extended test repertoire time donation , day one , test repertoire repeat one week donation , day eight . Iron supplement define as100 mg iron-sulphate ( Ferro retard ) , take day . Subjects randomise two group ; group : `` iron supplement '' , n = 100 , group b : `` iron supplement '' , n = 100 . These group stratify accord gender age . Randomising do without knowledge earlier blood test . Subjects ask participate arrive blood donation , oral write information . Questionnaire establish donor use day one . Day eight , follow-up iron supplement control . Dropouts withdrawal : Subjects receive iron supplement risk develop iron deficiency . Criteria transfer treatment group : - Females : Hb &lt; 12.5 g/dL - Males : Hb &lt; 13.5 g/dL These subject may continue participant study , description transfer treatment group include date treatment type ( iron supplement type dose , dose interval , treatment time , termination treatment ) . Ethics : The study approve regional ethic committee . All subject must sign informed consent . Data analysis : Univariate multivariate analysis use iron status variable , separate analysis gender . Baseline data take day one , donation , follow test day eight . Dependent variables haemoglobin , S-ferritin , total reticulocyte count , haemoglobin content reticulocytes percent hypochromated red cell . Independent variable gender , age , ironsupplement/ iron supplement . Biochemical test : Test method specify , instrument describe . Biochemical test perform lab clinical biochemistry , Haukeland University Hospital , Bergen .</detailed_description>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Must accept blood donor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>iron status</keyword>
	<keyword>blood donor</keyword>
</DOC>